CD274 and neoplasm: More recently, a preclinical study in malignant peripheral nerves sheath tumors or MPNSTs noted that treatment with the combination leads to plasma cell infiltration, sensitization to PD-L1 blockade and tumor regression in an immunocompetent model [37].